NCT01576666 Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01576380 A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients Status COMPLETED Phase PHASE2
NCT01576367 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Status COMPLETED Phase PHASE3
NCT01574651 The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01572727 A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Status COMPLETED Phase PHASE2/PHASE3
NCT01570686 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension Status COMPLETED Phase PHASE4
NCT01569828 Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function Status COMPLETED Phase PHASE2
NCT01569815 Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function Status COMPLETED Phase PHASE1
NCT01568762 To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma Status COMPLETED Phase PHASE1
NCT01566630 Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia Status TERMINATED Phase PHASE2
NCT01566604 Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE3
NCT01565902 Pharmacokinetics of BAF312 in Patients With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT01565096 Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy Status UNKNOWN Phase PHASE4
NCT01563354 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial Status COMPLETED Phase PHASE2
NCT01562041 Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease Status TERMINATED Phase PHASE2
NCT01558739 Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF) Status COMPLETED Phase PHASE4
NCT01558323 Pharmacokinetics of LCQ908 in Patients With Renal Impairment Status COMPLETED Phase PHASE1
NCT01555151 Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma Status COMPLETED Phase PHASE2
NCT01555138 Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.) Status COMPLETED Phase PHASE4
NCT01555125 First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks Status COMPLETED Phase PHASE3